BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23808814)

  • 21. A novel mutation in the JH4 domain of JAK3 causing severe combined immunodeficiency complicated by vertebral osteomyelitis.
    Qamar F; Junejo S; Qureshi S; Seleman M; Bainter W; Massaad M; Chou J; Geha RS
    Clin Immunol; 2017 Oct; 183():198-200. PubMed ID: 28917720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
    Tsuyama N; Asaka R; Dobashi A; Baba S; Mishima Y; Ueda K; Oguchi M; Tsuji H; Hatake K; Takeuchi K
    Hematol Oncol; 2018 Feb; 36(1):328-335. PubMed ID: 28695659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
    Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
    Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications.
    Li SD; Ma M; Li H; Waluszko A; Sidorenko T; Schadt EE; Zhang DY; Chen R; Ye F
    Genome Med; 2017 Oct; 9(1):89. PubMed ID: 29082853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
    Donner LR
    Pediatr Dev Pathol; 2008; 11(4):325; author reply 326. PubMed ID: 18839448
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of mutant alleles of JAK3 in pediatric patients with acute lymphoblastic leukemia.
    Yin C; Sandoval C; Baeg GH
    Leuk Lymphoma; 2015 May; 56(5):1502-6. PubMed ID: 25146434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive natural killer-cell neoplasm presenting in the marrow: a report of two cases including one with gains of chromosomes 4q and 9p.
    Jhuang JY; Clipson A; Hsieh YC; Yang CC; Chang ST; Du MQ; Chuang SS
    Diagn Pathol; 2015 Jul; 10():88. PubMed ID: 26141723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome.
    Sato T; Toki T; Kanezaki R; Xu G; Terui K; Kanegane H; Miura M; Adachi S; Migita M; Morinaga S; Nakano T; Endo M; Kojima S; Kiyoi H; Mano H; Ito E
    Br J Haematol; 2008 May; 141(5):681-8. PubMed ID: 18397343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting.
    Chang CW; Lai YS; Westin E; Khodadadi-Jamayran A; Pawlik KM; Lamb LS; Goldman FD; Townes TM
    Cell Rep; 2015 Sep; 12(10):1668-77. PubMed ID: 26321643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JAK3 pathway is constitutively active in B-lineage acute lymphoblastic leukemia.
    Uckun FM; Pitt J; Qazi S
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):37-48. PubMed ID: 21070101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms].
    Liang Q; Ye ZY; Su ZL; Lin HL; Shao CK; Lin SX; Rao HL; Mei KY; Zhao T; Liu YH; Luo DL; Zhu MG; Chen SH; Lin TY
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):291-5. PubMed ID: 20654150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a homozygous JAK3 V674A mutation caused by acquired uniparental disomy in a relapsed early T-cell precursor ALL patient.
    Kawashima-Goto S; Imamura T; Seki M; Kato M; Yoshida K; Sugimoto A; Kaneda D; Fujiki A; Miyachi M; Nakatani T; Osone S; Ishida H; Taki T; Takita J; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Hosoi H
    Int J Hematol; 2015 Apr; 101(4):411-6. PubMed ID: 25430085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of single-nucleotide polymorphisms for extranodal natural killer/T-cell lymphoma: the identification of risk factors in the molecular era.
    Yoon SE; Kim WS
    Cancer Commun (Lond); 2021 Nov; 41(11):1232-1233. PubMed ID: 34523265
    [No Abstract]   [Full Text] [Related]  

  • 34. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype.
    Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Shimizu N; Reghunathan R; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ
    Leuk Lymphoma; 2015; 56(8):2408-15. PubMed ID: 25382618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular underpinning of extranodal NK/T-cell lymphoma.
    Huang Y; de Leval L; Gaulard P
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects.
    Riera L; Lasorsa E; Bonello L; Sismondi F; Tondat F; Di Bello C; Di Celle PF; Chiarle R; Godio L; Pich A; Facchetti F; Ponzoni M; Marmont F; Zanon C; Bardelli A; Inghirami G
    Leuk Lymphoma; 2011 Sep; 52(9):1742-50. PubMed ID: 21599579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary central nervous system extranodal nasal-type natural killer/T-cell lymphoma with CD20 expression.
    Li D; Fu F; Lian L
    Neuropathology; 2018 Apr; 38(2):198-204. PubMed ID: 29063643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cell-type-specific mutations in nodal T-cell lymphomas.
    Nguyen TB; Sakata-Yanagimoto M; Asabe Y; Matsubara D; Kano J; Yoshida K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Izutsu K; Nakamura N; Takeuchi K; Miyoshi H; Ohshima K; Minowa T; Ogawa S; Noguchi M; Chiba S
    Blood Cancer J; 2017 Jan; 7(1):e516. PubMed ID: 28157189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group.
    Bresolin S; De Filippi P; Vendemini F; D'Alia M; Zecca M; Meyer LH; Danesino C; Locatelli F; Masetti R; Basso G; Te Kronnie G
    Oncotarget; 2016 May; 7(20):28914-9. PubMed ID: 26980750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-13 and IL-13Rα1 are overexpressed in extranodal natural killer/T cell lymphoma and mediate tumor cell proliferation.
    Zhang Y; Li C; Zhang M; Li Z
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2715-2720. PubMed ID: 30107911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.